Do regulatory agencies accept steady-state equivalence studies? [Design Issues]

posted by libaiyi – China, 2024-12-04 09:34 (212 d 07:00 ago) – Posting: # 24307
Views: 5,557

Dear friend,

I am currently conducting a single-dose bioequivalence study, but it is difficult to achieve equivalence due to high variability. I am wondering if it is possible to design a steady-state bioequivalence study, but I don't know if regulatory agencies accept steady-state BE studies like this, if there have been successful precedents for such a design, and what the conditions for its application are. Many thanks.


Libaiyi

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
26 visitors (0 registered, 26 guests [including 6 identified bots]).
Forum time: 17:34 CEST (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5